AD-Risikodiagnostik baut Ängste vor Alzheimer ab

Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimers Dement 7:270–279

Brayne C (2014) A population perspective on the IWG-2 research diagnostic criteria for Alzheimer’s disease. Lancet Neurol 13(6):532–534

Buchert R (2008) On the effect of sample size of the normal database on statistical power of single subject analysis. Nucl Med Commun 29:837–841

Geuze E, Vermetten E, Bremner JD (2005) MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. Mol Psychiatry 10:147–159

McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269

Niemantsverdriet E, Goossens J, Struyfs H et al (2016) Diagnostic impact of cerebrospinal fluid Biomarker (pre-)analytical variability in alzheimer’s disease. J Alzheimers Dis 51(1):97–106

Smith et al (2007) Brain structural alterations before mild cognitive impairment. Neurology 68:1268–1273

Suppa P, Anker U, Spies L et al (2015a) Fully automated atlas-based hippocampal volumetry for detection of Alzheimer’s disease in a memory clinic setting. J Alzheimers Dis 44:183–193

Suppa P, Hampel H, Spies L, Fiebach J, Dubois B, Buchert R (2015b) Fully automated atlas-based hippocampal volumetry for clinical routine: validation in subjects with mild cognitive impairment from the ADNI cohort. J Alzheimers Dis 46:199–209

Visser PJ et al (2002) Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72:491–497